Collection of Samples USOPTIVAL Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel: Evaluate the performance of a preliminary panel of biomarkers
Study summary
A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.
Eligibility
Primary outcome measure(s)
- Samples Collected for Plasma Circulating Free-DNA (cfDNA) Marker Testing — Within 12 months of sample collection
Samples Collected for Testing
Trial sites (16)
| Facility | City | Region | Status |
|---|---|---|---|
| Precision Recearch Institute | Chula Vista | California | Completed |
| Precision Research Institute | San Diego | California | Completed |
| Medical Associates Research Group | San Diego | California | Completed |
| Clinical Research of California | Walnut Creek | California | Completed |
| Center for Gastrointestinal Disorders | Hollywood | Florida | Completed |
| Lakeland Regional Cancer Center | Lakeland | Florida | Recruiting |
| Springfield Clinic | Springfield | Illinois | Recruiting |
| Ochsner Clinic | New Orleans | Louisiana | Completed |
| Dana Farber Cancer Institute | Boston | Massachusetts | Completed |
| Mid Hudson Medical Research | New Windsor | New York | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | Recruiting |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | Completed |
| Frontier Clinical Research | Uniontown | Pennsylvania | Completed |
| Clinical Trials Network | Union City | Tennessee | Completed |
| Vilo Research Group | Houston | Texas | Completed |
| Gastroenterology Consultants of SW Virginia | Raonoke | Virginia | Completed |
More Universal Diagnostics trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04792684 on ClinicalTrials.gov ↗ ← All trials in the USA